Researchers at the University of California designed a chemical called Denaq that alters the chemistry of retinal ganglion cells and allows electrical signals to be sent to the brain. Tests show that injecting Denaq into the eyes of blind mice restored a degree of vision and were able to detect light a week after injection. However, it was not clear how well the mice could see and will take several years until the chemical can be used to increase light sensitivity in human eyes.
What are your thoughts about Denaq as a potential future treatment of retinitis pigmentosa and age related macular degeneration?
For more information please visit BBC News
Image courtesy of [Pixomar]/FreeDigitalPhotos.net